These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

163 related items for PubMed ID: 11980003

  • 1. [Role of uropontin in calcium oxalate lithogenesis].
    Paulhac P, Desgrandchamps F, Dumas JP, Teillac P, Le Duc A, Colombeau P.
    Prog Urol; 2002 Feb; 12(1):114-7. PubMed ID: 11980003
    [Abstract] [Full Text] [Related]

  • 2. Uropontin in urinary calcium stone formation.
    Hoyer JR.
    Miner Electrolyte Metab; 1994 Feb; 20(6):385-92. PubMed ID: 7783701
    [Abstract] [Full Text] [Related]

  • 3. Ultrastructural immunodetection of osteopontin and osteocalcin as major matrix components of renal calculi.
    McKee MD, Nanci A, Khan SR.
    J Bone Miner Res; 1995 Dec; 10(12):1913-29. PubMed ID: 8619372
    [Abstract] [Full Text] [Related]

  • 4. Inhibitors of stone formation.
    Worcester EM.
    Semin Nephrol; 1996 Sep; 16(5):474-86. PubMed ID: 8890402
    [Abstract] [Full Text] [Related]

  • 5. Effects of microgravity on urinary osteopontin.
    Hoyer JR, Pietrzyk RA, Liu H, Whitson PA.
    J Am Soc Nephrol; 1999 Nov; 10 Suppl 14():S389-93. PubMed ID: 10541270
    [Abstract] [Full Text] [Related]

  • 6. Quantitative studies of human urinary excretion of uropontin.
    Min W, Shiraga H, Chalko C, Goldfarb S, Krishna GG, Hoyer JR.
    Kidney Int; 1998 Jan; 53(1):189-93. PubMed ID: 9453017
    [Abstract] [Full Text] [Related]

  • 7. Contribution of human uropontin to inhibition of calcium oxalate crystallization.
    Asplin JR, Arsenault D, Parks JH, Coe FL, Hoyer JR.
    Kidney Int; 1998 Jan; 53(1):194-9. PubMed ID: 9453018
    [Abstract] [Full Text] [Related]

  • 8. Detection of osteopontin as matrix protein in calcium-containing urinary stones.
    Yamate T, Umekawa T, Iguchi M, Kurita T, Kohri K.
    Hinyokika Kiyo; 1997 Sep; 43(9):623-7. PubMed ID: 9365840
    [Abstract] [Full Text] [Related]

  • 9. Oxalate: from crystal formation to crystal retention.
    Koul HK, Koul S, Fu S, Santosham V, Seikhon A, Menon M.
    J Am Soc Nephrol; 1999 Nov; 10 Suppl 14():S417-21. PubMed ID: 10541276
    [Abstract] [Full Text] [Related]

  • 10. Role of nephrocalcin in inhibition of calcium oxalate crystallization and nephrolithiasis.
    Coe FL, Nakagawa Y, Asplin J, Parks JH.
    Miner Electrolyte Metab; 1994 Nov; 20(6):378-84. PubMed ID: 7783700
    [Abstract] [Full Text] [Related]

  • 11. Intracrystalline proteins and urolithiasis: a comparison of the protein content and ultrastructure of urinary calcium oxalate monohydrate and dihydrate crystals.
    Ryall RL, Chauvet MC, Grover PK.
    BJU Int; 2005 Sep; 96(4):654-63. PubMed ID: 16104927
    [Abstract] [Full Text] [Related]

  • 12. Osteopontin antisense oligonucleotide inhibits adhesion of calcium oxalate crystals in Madin-Darby canine kidney cell.
    Yamate T, Kohri K, Umekawa T, Iguchi M, Kurita T.
    J Urol; 1998 Oct; 160(4):1506-12. PubMed ID: 9751404
    [Abstract] [Full Text] [Related]

  • 13. [Future perspective on the prevention of nephrolithiasis].
    Kohjimoto Y, Shinka T, Morimoto S, Nishihata M.
    Hinyokika Kiyo; 2004 Aug; 50(8):591-6. PubMed ID: 15471083
    [Abstract] [Full Text] [Related]

  • 14. Epitaxial deposition of calcium oxalate on uric acid rich stone matrix is induced by a 29 kDa protein.
    Srinivasan S, Kalaiselvi P, Varalakshmi P.
    Clin Chim Acta; 2006 Feb; 364(1-2):267-74. PubMed ID: 16139257
    [Abstract] [Full Text] [Related]

  • 15. Role of calcium oxalate monohydrate crystal interactions with renal epithelial cells in the pathogenesis of nephrolithiasis: a review.
    Lieske JC, Hammes MS, Toback FG.
    Scanning Microsc; 1996 Feb; 10(2):519-33; discussion 533-4. PubMed ID: 9813629
    [Abstract] [Full Text] [Related]

  • 16. Urinary calcium oxalate crystal growth inhibitors.
    Worcester EM.
    J Am Soc Nephrol; 1994 Nov; 5(5 Suppl 1):S46-53. PubMed ID: 7873744
    [Abstract] [Full Text] [Related]

  • 17. Mechanism underlying the low prevalence of pediatric calcium oxalate urolithiasis.
    Momohara C, Tsujihata M, Yoshioka I, Tsujimura A, Nonomura N, Okuyama A.
    J Urol; 2009 Sep; 182(3):1201-9. PubMed ID: 19625038
    [Abstract] [Full Text] [Related]

  • 18. Uric acid: an abettor or protector in calcium oxalate urolithiasis? Biochemical study in stone formers.
    Srinivasan S, Kalaiselvi P, Sakthivel R, Pragasam V, Muthu V, Varalakshmi P.
    Clin Chim Acta; 2005 Mar; 353(1-2):45-51. PubMed ID: 15698589
    [Abstract] [Full Text] [Related]

  • 19. Oxalate-induced damage to renal tubular cells.
    Scheid CR, Koul HK, Kennington L, Hill WA, Luber-Narod J, Jonassen J, Honeyman T, Menon M.
    Scanning Microsc; 1995 Mar; 9(4):1097-105; discussion 1105-7. PubMed ID: 8819891
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.